Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-3-17
|
pubmed:abstractText |
A predominant mutation within the BRCA1 predisposition gene, 185delAG, has been detected in about 1% of the Ashkenazi population, considered a high-risk group for breast and ovarian cancers. We examined 639 unrelated healthy Jews of Iraqi extraction, a presumed low-risk group, for the existence of this mutation. Three individuals were identified as 185delAG mutation carriers, and haplotype analysis of the Iraqi mutation carriers revealed that 2 of the Iraqis shared a common haplotype with 6 Ashkenazi mutation carriers, and 1 had a haplotype which differed by a single marker. This study suggests that the BRCA1 185delAG mutation also occurs in populations considered at low-risk for breast and ovarian cancers, and that it might have occurred prior to the dispersion of the Jewish people in the Diaspora, at least at the time of Christ.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1018-4813
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
413-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9450187-Adult,
pubmed-meshheading:9450187-Aged,
pubmed-meshheading:9450187-Alleles,
pubmed-meshheading:9450187-Breast Neoplasms,
pubmed-meshheading:9450187-Female,
pubmed-meshheading:9450187-Genes, BRCA1,
pubmed-meshheading:9450187-Genetic Markers,
pubmed-meshheading:9450187-Haplotypes,
pubmed-meshheading:9450187-Heterozygote,
pubmed-meshheading:9450187-Humans,
pubmed-meshheading:9450187-Israel,
pubmed-meshheading:9450187-Jews,
pubmed-meshheading:9450187-Male,
pubmed-meshheading:9450187-Middle Aged,
pubmed-meshheading:9450187-Mutation,
pubmed-meshheading:9450187-Risk Factors
|
pubmed:articleTitle |
Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?
|
pubmed:affiliation |
Susanne Levy Oncogenetics Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
|
pubmed:publicationType |
Journal Article
|